18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma
Authors:
Open Access
- 1 April 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 51 (1) , 1-8
Abstract
Background: Hypopharyngeal squamous cell carcinoma (HPSCC) has a high rate of distant metastasis, resulting in poor prognosis. The role of the maximum standardized uptake value (SUVmax), which was assessed via pretreatment 18-fluorodeoxyglucose positron emission tomography (FDG-PET), and computed tomography (CT) was examined, for predicting distant metastasis and survival. Methods: This study included 121 patients who underwent pretreatment FDG-PET/CT scanning and subsequent treatment for HPSCC. The SUVmax was measured via FDG-PET/CT. A receiver operating characteristic (ROC) curve analysis was used to determine whether the SUVmax was a predictor of distant metastasis and to select the best cutoff value. Univariate and multivariate Cox hazard regression analyses were used in identifying associations between the SUVmax and other clinicopathological factors with distant metastasis-free survival. Results: Distant metastases were identified in 33 patients during the median follow-up of 24 months after treatment. The ROC curve analysis determined that SUVmax was predictive of distant metastasis and identified a SUVmax of 13.9 as the best potential cutoff value. The univariate analysis showed that T and N classification, clinical stage, and SUVmax were significantly related to distant metastasis. However, in multivariate analysis, an SUVmax ≥ 13.9 was the only independent predictor of distant metastasis. Patients with high SUVmax values displayed significantly shorter distant metastasis-free survival and overall survival. Conclusions: SUVmax determined via pretreatment FDG-PET/CT is useful for predicting distant metastasis, distant metastasis-free survival, and overall survival in patients with HPSCC. GraphicalKeywords
Funding Information
- KAKENHI (18K09337)
This publication has 25 references indexed in Scilit:
- Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-AnalysisJournal of Nuclear Medicine, 2014
- 18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinomaAnnals of Nuclear Medicine, 2013
- Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynxAnnals of Oncology, 2012
- Treatment outcomes of definitive chemoradiotherapy for patients with hypopharyngeal cancerJournal of Radiation Research, 2012
- Relationship Between Hematotoxicity and Serum Albumin Level in the Treatment of Head and Neck Cancers with Concurrent Chemoradiotherapy Using CisplatinJapanese Journal of Clinical Oncology, 2011
- Targeting hypoxia in cancer therapyNature Reviews Cancer, 2011
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trialEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Distant Metastases from Laryngeal and Hypopharyngeal CancerORL, 2001
- Metastatic patterns in squamous cell cancer of the head and neckThe American Journal of Surgery, 1987